Close

Ratings by Piper Sandler (Joseph Catanzaro)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/5/2024 Achilles Therapeutics ACHL Downgrade Neutral
(Overweight)
1.20
(0.80)
-33.33% Details
3/27/2024 LENZ Therapeutics Inc LENZ New Coverage Overweight
(N/A)
16.32
(17.12)
4.9% Details
3/25/2024 Immunitybio Inc IBRX Maintain Neutral
(N/A)
 
 
  Details
3/18/2024 Leap Therapeutics LPTX Maintain Overweight
(N/A)
 
 
  Details
3/18/2024 I-Mab IMAB Maintain Overweight
(N/A)
 
 
  Details
3/14/2024 Iovanace Biotherapeutics IOVA Maintain Overweight
(N/A)
 
 
  Details
3/11/2024 Revolution RVMD New Coverage Overweight
(N/A)
31.53
(37.11)
17.7% Details
3/1/2024 Cardiff Oncology CRDF Maintain Overweight
(N/A)
 
 
  Details
2/29/2024 Schrodinger SDGR Maintain Overweight
(N/A)
 
 
  Details
2/26/2024 Ocular Therapeutix OCUL Maintain Overweight
(N/A)
 
 
  Details
2/20/2024 Iovanace Biotherapeutics IOVA Maintain Overweight
(N/A)
 
 
  Details
2/12/2024 Tango Therapeutics Inc. TNGX New Coverage Overweight
(N/A)
12.16
(7.52)
-38.16% Details
2/7/2024 Gilead Sciences GILD Maintain Overweight
(N/A)
 
 
  Details
12/27/2023 Gracell Biotechnologies Inc GRCL Downgrade Neutral
(Overweight)
6.19
(10.25)
65.59% Details
12/15/2023 Aadi Bioscience Inc AADI Maintain Overweight
(N/A)
 
 
  Details
12/4/2023 Immunogen Inc. IMGN Downgrade Neutral
(Overweight)
29.35
(31.25)
6.47% Details
11/7/2023 Halozyme Therapeutics HALO Maintain Overweight
(N/A)
 
 
  Details
10/16/2023 Repare Therapeutics RPTX Maintain Overweight
(N/A)
 
 
  Details
10/10/2023 Mirati Therapeutics MRTX Downgrade Neutral
(Overweight)
60.20
(58.70)
-2.49% Details
8/15/2023 Turnstone Biologics TSBX New Coverage Overweight
(N/A)
12.00
(2.64)
-78% Details
8/9/2023 Halozyme Therapeutics HALO Maintain Overweight
(N/A)
 
 
  Details
8/9/2023 Mirati Therapeutics MRTX New Coverage Overweight
(N/A)
28.06
(58.70)
109.19% Details
6/26/2023 Biomea Fusion Inc. BMEA Maintain Overweight
(N/A)
 
 
  Details
5/23/2023 Rain Therapeutics RAIN Downgrade Neutral
(Overweight)
9.93
(1.21)
-87.81% Details
5/12/2023 Immunitybio Inc IBRX Downgrade Neutral
(Overweight)
6.22
(5.07)
-18.49% Details
5/10/2023 Halozyme Therapeutics HALO Upgrade Overweight
(Neutral)
30.28
(38.07)
25.73% Details
5/10/2023 Exelixis EXEL New Coverage Overweight
(N/A)
19.03
(22.82)
19.92% Details
5/5/2023 Keros Therapeutics KROS Maintain Overweight
(N/A)
 
 
  Details
5/5/2023 Schrodinger SDGR New Coverage Overweight
(N/A)
29.15
(25.14)
-13.76% Details
5/3/2023 Immunogen Inc. IMGN Upgrade Overweight
(Neutral)
5.20
(31.25)
500.96% Details
4/28/2023 Gilead Sciences GILD New Coverage Overweight
(N/A)
83.74
(66.04)
-21.14% Details
4/3/2023 I-Mab IMAB Maintain Overweight
(N/A)
 
 
  Details
3/31/2023 Harpoon Therapeutics HARP Maintain Overweight
(N/A)
 
 
  Details
3/29/2023 Biomea Fusion Inc. BMEA Maintain Overweight
(N/A)
 
 
  Details
1/27/2023 Iovanace Biotherapeutics IOVA Upgrade Overweight
(Neutral)
7.74
(11.77)
52.07% Details
1/20/2023 Rain Therapeutics RAIN Maintain Overweight
(N/A)
 
 
  Details
1/17/2023 Leap Therapeutics LPTX Maintain Overweight
(N/A)
 
 
  Details
1/6/2023 CytomX Therapeutics CTMX Maintain Neutral
(N/A)
 
 
  Details
12/20/2022 Catalyst Pharmaceutical Partners CPRX Maintain Overweight
(N/A)
 
 
  Details
12/12/2022 Acrivon Therapeutics Inc ACRV New Coverage Overweight
(N/A)
12.50
(11.02)
-11.84% Details
12/7/2022 Achilles Therapeutics ACHL Maintain Overweight
(N/A)
 
 
  Details
11/21/2022 Iovanace Biotherapeutics IOVA Maintain Neutral
(N/A)
 
 
  Details
11/8/2022 Oyster Point Pharma OYST Downgrade Neutral
(Overweight)
8.35
(11.17)
33.77% Details
9/13/2022 Cardiff Oncology CRDF Maintain Overweight
(N/A)
 
 
  Details
8/31/2022 I-Mab IMAB Maintain Overweight
(N/A)
 
 
  Details
8/11/2022 Harpoon Therapeutics HARP Maintain Overweight
(N/A)
 
 
  Details
8/11/2022 Catalyst Pharmaceutical Partners CPRX Maintain Overweight
(N/A)
 
 
  Details
8/10/2022 Halozyme Therapeutics HALO Maintain Neutral
(N/A)
 
 
  Details
8/5/2022 CytomX Therapeutics CTMX Maintain Neutral
(N/A)
 
 
  Details
7/7/2022 CytomX Therapeutics CTMX Downgrade Neutral
(Overweight)
1.94
(1.79)
-7.73% Details
6/2/2022 Repare Therapeutics RPTX Maintain Overweight
(N/A)
 
 
  Details
5/31/2022 Rain Therapeutics RAIN Maintain Overweight
(N/A)
 
 
  Details
5/31/2022 Oyster Point Pharma OYST Maintain Overweight
(N/A)
 
 
  Details
5/31/2022 Ocular Therapeutix OCUL Maintain Overweight
(N/A)
 
 
  Details
5/31/2022 Neoleukin Therapeutics NLTX Maintain Overweight
(N/A)
 
 
  Details
5/31/2022 Marker Therapeutics MRKR Maintain Overweight
(N/A)
 
 
  Details
5/31/2022 Leap Therapeutics LPTX Maintain Overweight
(N/A)
 
 
  Details
5/31/2022 I-Mab IMAB Maintain Overweight
(N/A)
 
 
  Details
5/31/2022 Immunitybio Inc IBRX Maintain Overweight
(N/A)
 
 
  Details
5/31/2022 Harpoon Therapeutics HARP Maintain Overweight
(N/A)
 
 
  Details
5/31/2022 Gracell Biotechnologies Inc GRCL Maintain Overweight
(N/A)
 
 
  Details
5/31/2022 CytomX Therapeutics CTMX Maintain Overweight
(N/A)
 
 
  Details
5/31/2022 Cardiff Oncology CRDF Maintain Overweight
(N/A)
 
 
  Details
5/31/2022 Biomea Fusion Inc. BMEA Maintain Overweight
(N/A)
 
 
  Details
5/31/2022 Achilles Therapeutics ACHL Maintain Overweight
(N/A)
 
 
  Details
5/12/2022 Sensei Biotherapeutics SNSE Maintain Overweight
(N/A)
 
 
  Details
5/10/2022 Ocular Therapeutix OCUL Maintain Overweight
(N/A)
 
 
  Details
5/5/2022 Connect Biopharma Holdings Ltd CNTB Downgrade Neutral
(Overweight)
1.94
(1.44)
-25.77% Details
3/17/2022 Catalyst Pharmaceutical Partners CPRX Maintain Neutral
(N/A)
 
 
  Details
3/14/2022 Harpoon Therapeutics HARP Maintain Overweight
(N/A)
 
 
  Details
3/10/2022 Sensei Biotherapeutics SNSE Maintain Overweight
(N/A)
 
 
  Details
3/9/2022 Figs Inc. FIGS Maintain Overweight
(N/A)
 
 
  Details
3/2/2022 Neoleukin Therapeutics NLTX Maintain Overweight
(N/A)
 
 
  Details
2/28/2022 Cardiff Oncology CRDF Maintain Overweight
(N/A)
 
 
  Details
2/17/2022 Marker Therapeutics MRKR Maintain Overweight
(N/A)
 
 
  Details
2/7/2022 Catalyst Pharmaceutical Partners CPRX Maintain Overweight
(N/A)
 
 
  Details
1/26/2022 Halozyme Therapeutics HALO Maintain Neutral
(N/A)
 
 
  Details
1/6/2022 Connect Biopharma Holdings Ltd CNTB Maintain Overweight
(N/A)
 
 
  Details
11/3/2021 Halozyme Therapeutics HALO Maintain Neutral
(N/A)
 
 
  Details
10/29/2021 Seagen SGEN Maintain Neutral
(N/A)
 
 
  Details
10/25/2021 Ocular Therapeutix OCUL Maintain Overweight
(N/A)
 
 
  Details
9/20/2021 Seagen SGEN Maintain Neutral
(N/A)
 
 
  Details
9/16/2021 Repare Therapeutics RPTX Maintain Overweight
(N/A)
 
 
  Details
9/8/2021 Aadi Bioscience Inc AADI New Coverage Overweight
(N/A)
26.48
(1.80)
-93.2% Details
8/30/2021 Figs Inc. FIGS Maintain Overweight
(N/A)
 
 
  Details
8/13/2021 Figs Inc. FIGS Maintain Overweight
(N/A)
 
 
  Details
8/9/2021 Figs Inc. FIGS Maintain Overweight
(N/A)
 
 
  Details
8/6/2021 Neoleukin Therapeutics NLTX New Coverage Overweight
(N/A)
6.65
(3.49)
-47.52% Details
7/23/2021 Ocular Therapeutix OCUL Maintain Overweight
(N/A)
 
 
  Details
7/6/2021 Sensei Biotherapeutics SNSE Maintain Overweight
(N/A)
 
 
  Details
6/21/2021 Figs Inc. FIGS New Coverage Overweight
(N/A)
36.51
(4.62)
-87.35% Details
5/20/2021 Iovanace Biotherapeutics IOVA Downgrade Neutral
(Overweight)
26.97
(11.77)
-56.36% Details
5/19/2021 Iovanace Biotherapeutics IOVA Maintain Overweight
(N/A)
 
 
  Details
5/18/2021 Rain Therapeutics RAIN New Coverage Overweight
(N/A)
15.33
(1.21)
-92.11% Details
5/11/2021 Halozyme Therapeutics HALO Downgrade Neutral
(Overweight)
47.57
(38.07)
-19.97% Details
5/11/2021 Biomea Fusion Inc. BMEA New Coverage Overweight
(N/A)
16.94
(11.29)
-33.35% Details
5/10/2021 Harpoon Therapeutics HARP New Coverage Overweight
(N/A)
22.04
(23.01)
4.4% Details
5/6/2021 Global Blood Therapeutics GBT Maintain Neutral
(N/A)
 
 
  Details
4/26/2021 Achilles Therapeutics ACHL New Coverage Overweight
(N/A)
16.60
(0.80)
-95.18% Details
4/13/2021 Connect Biopharma Holdings Ltd CNTB New Coverage Overweight
(N/A)
17.05
(1.44)
-91.55% Details
3/25/2021 Marker Therapeutics MRKR New Coverage Overweight
(N/A)
2.58
(4.23)
63.95% Details
3/1/2021 Sensei Biotherapeutics SNSE New Coverage Overweight
(N/A)
16.29
(1.00)
-93.86% Details
2/12/2021 Seagen SGEN Maintain Neutral
(N/A)
 
 
  Details
1/20/2021 Global Blood Therapeutics GBT Downgrade Neutral
(Overweight)
49.92
(68.49)
37.2% Details
12/8/2020 Keros Therapeutics KROS Maintain Overweight
(N/A)
 
 
  Details
11/18/2020 Keros Therapeutics KROS Maintain Overweight
(N/A)
 
 
  Details
11/6/2020 Global Blood Therapeutics GBT Maintain Overweight
(N/A)
 
 
  Details
11/6/2020 Iovanace Biotherapeutics IOVA Maintain Overweight
(N/A)
 
 
  Details
10/8/2020 Cardiff Oncology CRDF New Coverage Overweight
(N/A)
12.87
(4.34)
-66.28% Details
10/6/2020 Iovanace Biotherapeutics IOVA Maintain Overweight
(N/A)
 
 
  Details
7/29/2020 Global Blood Therapeutics GBT Maintain Overweight
(N/A)
 
 
  Details
7/24/2020 Seattle Genetics SGEN Downgrade Neutral
(Overweight)
176.83
(228.74)
29.36% Details
7/22/2020 Ocular Therapeutix OCUL Maintain Overweight
(N/A)
 
 
  Details
7/14/2020 Repare Therapeutics RPTX Maintain Overweight
(N/A)
 
 
  Details
7/8/2020 NantKwest NK New Coverage Overweight
(N/A)
11.86
(32.49)
173.95% Details
7/6/2020 Immunomedics IMMU Maintain Overweight
(N/A)
 
 
  Details
7/2/2020 Halozyme Therapeutics HALO Maintain Overweight
(N/A)
 
 
  Details
5/27/2020 Keros Therapeutics KROS Maintain Overweight
(Overweight)
 
 
  Details
4/27/2020 Seattle Genetics SGEN Maintain Overweight
(N/A)
 
 
  Details
4/23/2020 Immunomedics IMMU Maintain Overweight
(N/A)
 
 
  Details
4/20/2020 Seattle Genetics SGEN Maintain Overweight
(N/A)
 
 
  Details
4/7/2020 XBiotech XBIT Maintain Overweight
(N/A)
 
 
  Details
3/4/2020 Ocular Therapeutix OCUL Maintain Overweight
(N/A)
 
 
  Details
2/26/2020 Iovanace Biotherapeutics IOVA Maintain Overweight
(N/A)
 
 
  Details
2/13/2020 Aerie Pharma AERI Maintain Overweight
(N/A)
 
 
  Details
2/7/2020 Seattle Genetics SGEN Maintain Overweight
(N/A)
 
 
  Details
2/5/2020 Halozyme Therapeutics HALO Upgrade Overweight
(Neutral)
19.21
(38.07)
98.18% Details
12/11/2019 XBiotech Inc. XBIT Maintain Overweight
(N/A)
 
 
  Details
11/8/2019 CytomX Therapeutics CTMX Maintain Overweight
(N/A)
 
 
  Details
11/7/2019 Aerie Pharma AERI Maintain Overweight
(N/A)
 
 
  Details
11/6/2019 Immunomedics IMMU Maintain Overweight
(N/A)
 
 
  Details
10/31/2019 Clovis Oncology CLVS Maintain Neutral
(N/A)
 
 
  Details
10/9/2019 Catalyst Pharmaceutical Partners CPRX Maintain Overweight
(N/A)
 
 
  Details
9/30/2019 Seattle Genetics SGEN Maintain Overweight
(N/A)
 
 
  Details
8/23/2019 NuCana NCNA Maintain Overweight
(N/A)
 
 
  Details
7/17/2019 Seattle Genetics SGEN Upgrade Overweight
(Neutral)
63.99
(228.74)
257.46% Details
6/28/2019 Iovanace Biotherapeutics IOVA Maintain Overweight
(Overweight)
 
 
  Details
6/28/2019 Iovanace Biotherapeutics IOVA Maintain Overweight
(N/A)
 
 
  Details
6/14/2019 XBiotech XBIT New Coverage Overweight
(N/A)
7.13
(8.20)
15.01% Details
5/21/2019 Ocular Therapeutix OCUL Maintain Overweight
(N/A)
 
 
  Details
5/8/2019 Aerie Pharma AERI Maintain Overweight
(N/A)
 
 
  Details
4/29/2019 Iovanace Biotherapeutics IOVA New Coverage Overweight
(N/A)
11.02
(11.77)
6.81% Details
4/15/2019 Clovis Oncology CLVS Maintain Neutral
(N/A)
 
 
  Details
3/21/2019 Aerie Pharma AERI New Coverage Overweight
(N/A)
45.64
(15.25)
-66.59% Details
3/11/2019 NuCana NCNA Maintain Overweight
(N/A)
 
 
  Details
3/1/2019 Immunogen Inc. IMGN Downgrade Neutral
(Overweight)
4.72
(31.25)
562.08% Details
2/27/2019 Clovis Oncology CLVS Maintain Neutral
(N/A)
 
 
  Details
2/8/2019 Seattle Genetics SGEN Maintain Neutral
(N/A)
 
 
  Details
2/6/2019 Stemline Therapeutics STML Maintain Overweight
(N/A)
 
 
  Details
12/13/2018 Catalyst Pharmaceutical Partners CPRX Maintain Overweight
(N/A)
 
 
  Details
11/26/2018 Stemline Therapeutics STML New Coverage Overweight
(N/A)
11.73
(11.83)
0.85% Details
11/26/2018 CytomX Therapeutics CTMX New Coverage Overweight
(N/A)
12.91
(1.79)
-86.13% Details
10/26/2018 Seattle Genetics SGEN Maintain Neutral
(N/A)
 
 
  Details
9/7/2018 Immunogen Inc. IMGN New Coverage Overweight
(N/A)
10.03
(4.72)
-52.94% Details
9/7/2018 Seattle Genetics SGEN New Coverage Neutral
(N/A)
76.96
(63.99)
-16.85% Details
9/7/2018 Catalyst Pharmaceutical Partners CPRX New Coverage Overweight
(N/A)
3.40
(15.75)
363.24% Details
9/7/2018 Ocular Therapeutix OCUL New Coverage Overweight
(N/A)
6.82
(6.45)
-5.43% Details